Clinical Trials Directory

Trials / Completed

CompletedNCT05237830

Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.

Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty: a Single-center Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.

Conditions

Interventions

TypeNameDescription
PROCEDUREUse of Cell Salvage in revision of total hip arthroplastyThe effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.

Timeline

Start date
2011-01-01
Primary completion
2021-12-31
Completion
2022-01-31
First posted
2022-02-14
Last updated
2022-02-14

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05237830. Inclusion in this directory is not an endorsement.